Long‐term efficacy of stent placement for treating inferior vena cava stenosis following liver transplantation
Jae Myeong Lee, Gi‐Young Ko, Kyu‐Bo Sung, Dong Il Gwon, Hyun‐Ki Yoon, Sung‐Gyu Lee – 21 January 2010 – The aims of this study were to evaluate both the efficacy of stent placement for treating inferior vena cava (IVC) stenosis and the patency of hepatic veins (HVs) following IVC stent placement. Fourteen hepatic transplant recipients underwent stent placement to treat IVC stenosis. The median interval between transplantation and stent placement was 32 days. Stents varied from 20‐36 mm in diameter and were 60‐120 mm long.
Pretransplant cryptococcosis and outcome after liver transplantation
Costi D. Sifri, Hsin‐Yun Sun, Thomas V. Cacciarelli, Brian Wispelwey, Timothy L. Pruett, Nina Singh – 21 January 2010 – The posttransplant outcomes and optimal management of patients with end‐stage liver disease who develop cryptococcosis prior to transplantation have not been defined. We discuss these issues in the context of successful liver transplantation and pretransplant cryptococcal disease.
Human leukocyte antigen antibodies in liver retransplantation
Adriana Zeevi, John G. Lunz – 21 January 2010
Prevention of de novo hepatitis B virus infections: More seems no better
David Mutimer – 21 January 2010
Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha‐2b
Elizabeth B. Haagsma, Annelies Riezebos‐Brilman, Arie P. van den Berg, Robert J. Porte, Hubert G. M. Niesters – 15 January 2010 – Hepatitis E virus (HEV) infections are known to run a self‐limiting course. Recently, chronic hepatitis E has been described in immunosuppressed patients after solid‐organ transplantation. Besides the general recommendation to lower the immunosuppressive medication in these patients, there is currently no specific treatment.
Successful endoscopic treatment of biliary cast syndrome in an orthotopic liver transplant patient with a Roux‐en‐Y anastomosis via balloon enteroscopy
Atif Saleem, Todd H. Baron – 15 January 2010
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease
Shahid M. Malik, Jawad Ahmad – 15 January 2010
Dual living donor liver transplantation with ABO‐incompatible and ABO‐compatible grafts to overcome small‐for‐size graft and ABO blood group barrier
Gi‐Won Song, Sung‐Gyu Lee, Shin Hwang, Ki‐Hum Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Seog‐Woon Kwon, Gi‐Young Ko, Kyoung‐Won Kim – 15 January 2010 – ABO blood group compatibility has been regarded as an essential prerequisite for successful adult living donor liver transplantation (LDLT). Novel strategies for overcoming the ABO blood group barrier, however, have markedly improved the results of ABO‐incompatible (ABOi) LDLT.
Severe novel H1N1 influenza A infection in the immediate postoperative period of a liver transplant patient
Rodrigo Zapata, Mario Uribe, Waldo Martínez, Alejandro Andrade, José Luis Leal, Fernando Gomez – 15 January 2010 – In 2009, the World Health Organization recognized the novel H1N1 influenza A virus as a pandemic infection. Since April 2009, thousands of cases of novel H1N1 influenza A infection have been reported worldwide, and they have resulted in thousands of deaths. South American countries were affected by this infection during their winter season, and Chile presented one of the highest incidence rates.